Home/Filings/4/0000899243-22-002654
4//SEC Filing

Desmarais William 4

Accession 0000899243-22-002654

CIK 0001783328other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:29 PM ET

Size

5.4 KB

Accession

0000899243-22-002654

Insider Transaction Report

Form 4
Period: 2022-01-18
Desmarais William
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-18+50,00050,000 total
    Exercise: $4.85Exp: 2032-01-17Voting Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1
  • filerCIK 0001860207

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:29 PM ET
Size
5.4 KB